Why Basel Medical Group Ltd’s (BMGL) Stock Is Up 5.64%
As of Thursday, July 02, Basel Medical Group Ltd’s BMGL share price has surged by 5.64%, which has investors questioning if this is right time to sell.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Jenna Brashear
Jenna Brashear
Jenna Brashear
| Share Statistics | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.1 | $1,721.2 | 5% |
|
| Shares Out (Mil) | 1.2 | 80.6 | 6% |
|
| Institutional Ownership | 11.3% | 87.6% | 6% |
|
| Float (Mil) | 12.5 | 59.2 | 22% |
|
| Beta | na | 0.74 | na |
|
| Avg Daily Volume (000s) | 9,482 | 613 | 96% |
|
| Price Change (52-week) |
(97.8%) | 74.5% | 3% |
|
| Growth | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.4% | na |
|
| Net Income (5yr) | na | (0.5%) | na |
|
| EPS (5yr) | na | 3.0% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.4%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $16 | $1,529 | 11% |
|
| Net Income (TTM) (Mil) | ($1) | $33 | 37% |
|
| EPS (TTM) | ($0.365) | $0.300 | 29% |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | $175 | 31% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $7 | 40% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $419 | 21% |
|
| Enterprise Value (Q1) (Mil) | $6 | $2,427 | 7% |
|
| Valuation | BMGL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.15 | 2.56 | 4% |
|
| P/E | na | 25.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 35.7% | 27.3% | 44% |
|
| Net Margin | (3.6%) | 1.4% | 26% |
|
| ROA | (4.1%) | 2.4% | 30% |
|
| ROE | (14.1%) | 7.3% | 25% |
|
| Liabilities to Assets | 74.5% | 62.3% | 70% |
|
| F-Score | 6 | 5 | 67% |
|
Basel Medical Group Ltd did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors